These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22988349)

  • 1. Current therapy and recent advances in the management of retinoblastoma.
    Meel R; Radhakrishnan V; Bakhshi S
    Indian J Med Paediatr Oncol; 2012 Apr; 33(2):80-8. PubMed ID: 22988349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic chemotherapy as a new conservative treatment for intraocular retinoblastoma.
    Yanagisawa T
    Int J Clin Oncol; 2004 Feb; 9(1):13-24. PubMed ID: 15162821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoreduction for unilateral retinoblastoma.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
    Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma.
    Zhao J; Feng ZX; Wei M; Liu G; Solarte CE; Li B; Wang Y; Zhang C; Gallie BL
    Ophthalmol Retina; 2020 Jun; 4(6):630-639. PubMed ID: 32387053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
    Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
    Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.
    Greenwald MJ; Strauss LC
    Ophthalmology; 1996 Dec; 103(12):1989-97. PubMed ID: 9003332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
    Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
    Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for retinoblastoma: a current topic.
    Finger PT; Czechonska G; Demirci H; Rausen A
    Drugs; 1999 Dec; 58(6):983-96. PubMed ID: 10651386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria.
    Sovinz P; Urban C; Lackner H; Benesch M; Langmann G
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):22-30. PubMed ID: 16489522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
    Gündüz K; Shields CL; Shields JA; Meadows AT; Gross N; Cater J; Needle M
    Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoblastoma in Turkey: results from a tertiary care center in Ankara.
    Gündüz K; Köse K; Kurt RA; Süren E; Taçyildiz N; Dinçaslan H; Ünal E; Erden E; Heper AO
    J Pediatr Ophthalmol Strabismus; 2013; 50(5):296-303. PubMed ID: 23937863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
    Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
    Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management strategies for intraocular retinoblastoma.
    Kim JW; Abramson DH; Dunkel IJ
    Drugs; 2007; 67(15):2173-85. PubMed ID: 17927283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
    Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
    Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
    J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoblastoma: A Sixteen-Year Review of the Presentation, Treatment, and Outcome from a Tertiary Care Institute in Northern India.
    Singh U; Katoch D; Kaur S; Dogra MR; Bansal D; Kapoor R
    Ocul Oncol Pathol; 2017 Dec; 4(1):23-32. PubMed ID: 29344495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.